Optimization of amino acid thioesters as inhibitors of metallo-β-lactamase L1

被引:16
作者
Liu, Xiao-Long [1 ]
Yang, Ke-Wu [1 ]
Zhang, Yue-Juan [1 ]
Ge, Ying [1 ]
Xiang, Yang [1 ]
Chang, Ya-Nan [1 ]
Oelschlaeger, Peter [2 ]
机构
[1] Northwest Univ, Coll Chem & Mat Sci, Key Lab Synthet & Nat Funct Mol Chem, Minist Educ,Chem Biol Innovat Lab, Xian 710127, Peoples R China
[2] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, 309 East Second St, Pomona, CA 91766 USA
基金
中国国家自然科学基金;
关键词
Antibiotic resistance; Metallo-beta-lactamase; L1; Inhibitor; Mercaptoacetic acid thioester; HIGHLY PROMISING SCAFFOLD; BROAD-SPECTRUM INHIBITOR; MERCAPTOCARBOXYLATE INHIBITOR; PSEUDOMONAS-AERUGINOSA; RECOGNITION; DERIVATIVES; DISCOVERY;
D O I
10.1016/j.bmcl.2016.08.048
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The emergence of antibiotic resistance caused by metallo-beta-lactamases (MbLs) is a global public health problem. Recently, we found amino acid thioesters to be a highly promising scaffold for inhibitors of the M beta L L1. In order to optimize this series of inhibitors, nine new amino acid thioesters were developed by modifying the substituents on the N-terminus of the thioesters and the groups representing the amino acid side chain. Biological activity assays indicate that all of them are very potent inhibitors of L1 with an IC50 value range of 20-600 nM, lower than those of most of the previously reported inhibitors of this scaffold. Analysis of structure-activity relationship reveals that big hydrophobic substituents on the N-terminus and a methionine amino acid side chain improves inhibitory activity of the thioesters. All these inhibitors are able to restore antibacterial activity of a beta-lactam antibiotic against Escherichia coli BL21(DE3) cells producing L1 to that against E. coli cells lacking a beta-lactamase. Docking studies reveal that a large N-terminal hydrophobic group results in a slightly different binding mode than smaller hydrophobic groups at the same position. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4698 / 4701
页数:4
相关论文
共 50 条
  • [41] Cephalosporin Prodrug Inhibitors Overcome Metallo-β-Lactamase Driven Antibiotic Resistance
    van Haren, Matthijs J.
    Tehrani, Kamaleddin H. M. E.
    Kotsogianni, Ioli
    Wade, Nicola
    Bruchle, Nora C.
    Mashayekhi, Vida
    Martin, Nathaniel I.
    CHEMISTRY-A EUROPEAN JOURNAL, 2021, 27 (11) : 3806 - 3811
  • [42] Design of dipicolinic acid derivatives as New Delhi metallo-β-lactamase-1 inhibitors using a combined computational approach
    Wang, Xiyan
    Gao, Yawen
    Yu, Yiding
    Yang, Yanan
    Wang, Guizhen
    Sun, Lin
    Niu, Xiaodi
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2020, 38 (11) : 3384 - 3395
  • [43] Rhodanine as a Potent Scaffold for the Development of Broad Spectrum Metallo-β-lactamase inhibitors
    Xiang, Yang
    Chen, Cheng
    Wang, Wen-Ming
    Xu, Li-Wei
    Yang, Ke-Wu
    Oelschlaeger, Peter
    He, Yuan
    ACS MEDICINAL CHEMISTRY LETTERS, 2018, 9 (04): : 359 - 364
  • [44] Interactions of hydrolyzed β-lactams with the L1 metallo-β-lactamase: Crystallography supports stereoselective binding of cephem/carbapenem products
    Hinchliffe, Philip
    Calvopina, Karina
    Rabe, Patrick
    Mojica, Maria F.
    Schofiled, Christopher J.
    Dmitrienko, Gary I.
    Bonomo, Robert A.
    Vila, Alejandro J.
    Spencer, James
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2023, 299 (05)
  • [45] How does electron exchange correlation influence reactivity of metallo-β-lactamase L1 against cephalosporin antibiotics
    Levina, Elena
    Tsirelson, Vladimir
    CHEMICAL PHYSICS, 2023, 566
  • [46] Benzimidazole and Benzoxazole Zinc Chelators as Inhibitors of Metallo-β-Lactamase NDM-1
    Jackson, Abigail C.
    Pinter, Tyler B. J.
    Talley, Daniel C.
    Baker-Agha, Adnan
    Patel, Dhruvil
    Smith, Paul J.
    Franz, Katherine J.
    CHEMMEDCHEM, 2021, 16 (04) : 654 - 661
  • [47] Computationally designed peptide macrocycle inhibitors of New Delhi metallo-β-lactamase 1
    Mulligan, Vikram Khipple
    Workman, Sean
    Sun, Tianjun
    Rettie, Stephen
    Li, Xinting
    Worrall, Liam J.
    Craven, Timothy W.
    King, Dustin T.
    Hosseinzadeh, Parisa
    Watkins, Andrew M.
    Renfrew, P. Douglas
    Guffy, Sharon
    Labonte, Jason W.
    Moretti, Rocco
    Bonneau, Richard
    Strynadka, Natalie C. J.
    Baker, David
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (12)
  • [48] Virtual Screening and Experimental Testing of B1 Metallo-β-lactamase Inhibitors
    Kang, Joon S.
    Zhang, Antonia L.
    Faheem, Mohammad
    Zhang, Charles J.
    Ai, Ni
    Buynak, John D.
    Welsh, William J.
    Oelschlaeger, Peter
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2018, 58 (09) : 1902 - 1914
  • [49] Recent Advances in the Discovery of Metallo-β-Lactamase Inhibitors for β-lactam Antibiotic-Resistant Reversing Agents
    Guo, Zhenzhen
    Ma, Shutao
    CURRENT DRUG TARGETS, 2014, 15 (07) : 689 - 702
  • [50] Cross-subclass metallo-β-lactamase inhibitors: From structural and catalytic commonalities guiding design
    Zhang, Yanhong
    Liang, Zhenyang
    Wang, Shuai
    Qiao, Renzhong
    Li, Chao
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 289